These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 2164200

  • 1. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
    Ukena D, Dent G, Chanez P, Barnes PJ, Sybrecht GW.
    Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
    [Abstract] [Full Text] [Related]

  • 2. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A, Tahraoui L, Sedivy P, Cavero I.
    J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 4. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L, Zuurbier AE, Mul FP, Verhoeven AJ, Lutter R, Knol EF, Roos D.
    J Immunol; 1998 Sep 15; 161(6):3064-70. PubMed ID: 9743372
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug 15; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct 15; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O, Robaut C, Cavero I.
    J Pharmacol Exp Ther; 1988 Feb 15; 244(2):709-15. PubMed ID: 2831350
    [Abstract] [Full Text] [Related]

  • 13. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC.
    J Lipid Mediat; 1993 Jun 15; 7(2):115-34. PubMed ID: 8400114
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stimulation of degranulation from human eosinophils by platelet-activating factor.
    Kroegel C, Yukawa T, Dent G, Venge P, Chung KF, Barnes PJ.
    J Immunol; 1989 May 15; 142(10):3518-26. PubMed ID: 2541198
    [Abstract] [Full Text] [Related]

  • 16. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB, Lam MH, Hsu AH.
    Mol Pharmacol; 1989 Jan 15; 35(1):48-58. PubMed ID: 2536468
    [Abstract] [Full Text] [Related]

  • 17. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA, Kroegel C, Barnes PJ.
    J Immunol; 1990 May 01; 144(9):3489-97. PubMed ID: 2158510
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ, Yaremko B, Selig WM, Janero DR, Burghardt C, Welton AF, O'Donnell M.
    J Pharmacol Exp Ther; 1991 Oct 01; 259(1):78-85. PubMed ID: 1656030
    [Abstract] [Full Text] [Related]

  • 19. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes.
    Marquis O, Robaut C, Cavero I.
    J Pharmacol Exp Ther; 1989 Jul 01; 250(1):293-300. PubMed ID: 2545861
    [Abstract] [Full Text] [Related]

  • 20. Hetrazepine PAF antagonists.
    Ikegami K, Meade CJ, Heuer HO, Birke F.
    J Lipid Mediat; 1992 Jul 01; 5(2):177-82. PubMed ID: 1326346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.